01:51 AM EDT, 10/21/2026 (MT Newswires) -- Eurofins Scientific (ERF.PA) lowered its organic growth target for 2026 and confirmed its objectives for 2027, according to a Wednesday release. The French laboratories group now expects organic growth in 2026 below its previous objective of mid-single-digit growth. Looking ahead, the company reiterated its expectations of a return to mid-single-digit organic growth in 2027.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.